News | October 25, 2024
Jagsonpal Pharmaceuticals Q2 FY25 net profit up at Rs. 11.45 Cr
Jagsonpal Pharmaceuticals has reported total income of Rs. 76.34 crores during the period ended September 30, 2024
Jagsonpal Pharmaceuticals has reported total income of Rs. 76.34 crores during the period ended September 30, 2024
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
Lamotrigine extended-release tablets are indicated for adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
Coupled with Shea Butter, Cocoa Butter, and Mango Butter, the balm provides deep hydration, ensuring lips remain soft, smooth, and well-moisturized throughout the day
Subscribe To Our Newsletter & Stay Updated
